NAUT — Nautilus Biotechnology Share News
0.000.00%
- $412.31m
- $328.28m
Nautilus Biotechnology Inc reports results for the quarter ended December 31 - Earnings Summary
Nautilus Biotechnology Inc expected to post a loss of 16 cents a share - Earnings Preview
Nautilus Biotechnology Inc reports results for the quarter ended in January 1 - Earnings Summary
Brief: Nautilus Biotechnology Q3 EPS USD -0.13
Brief: Nautilus Biotechnology QTRLY Loss Per Share $0.13
Nautilus Biotechnology Inc expected to post a loss of 16 cents a share - Earnings Preview
Brief: Nautilus Biotechnology Q2 EPS USD -0.14
Nautilus Biotechnology Inc expected to post a loss of 16 cents a share - Earnings Preview
Nautilus Biotechnology Inc reports results for the quarter ended in March - Earnings Summary
Brief: Nautilus Biotechnology Q1 EPS USD -0.15
Nautilus Biotechnology Inc expected to post a loss of 16 cents a share - Earnings Preview
Nautilus Biotechnology Inc reports results for the quarter ended in December - Earnings Summary
Brief: Nautilus Biotechnology Q4 EPS USD -0.14
Brief: Nautilus Bio Entered Sales Agreement With Cowen And Company To Sell Shares Of Common Stock Having Proceeds Of Up To $125 Mln
Brief: Nautilus Biotechnology Files For Mixed Shelf Offering Of Up To $300 Million - SEC Filing
Nautilus Biotechnology Inc expected to post a loss of 14 cents a share - Earnings Preview
Brief: Nautilus Biotechnology, Filed Suit Against Somalogic And California Institute Of Technology
Nautilus Biotechnology Inc reports results for the quarter ended in September - Earnings Summary
Brief: Nautilus Biotechnology Inc Cash, Cash Equivalents, And Investments Were $275.7 Million As Of September 30, 2023